|
Costimulatory Molecules
|
CE
|
SH
|
CH
| |
P Value
| |
|---|
|
Mean ± SD
|
Mean ± SD
|
Mean ± SD
|
CE vs SH
|
CE vs CH
|
SH vs CH
|
|---|
|
CTLA4
|
0.073 ± 0.099
|
0.182 ± 0.233
|
5.293 ± 16.949
|
0.1
|
0.07
|
0.1
|
|
CD28
|
0.087 ± 0.018
|
24.361 ± 22.860
|
71.128 ± 60.365
|
0.0001
|
<0.00001
|
0.1
|
|
CD80
|
50.779 ± 67.682
|
54.731 ± 74.778
|
67.712 ± 98.575
|
0.5
|
0.1
|
0.5
|
|
CD86
|
61.528 ± 117.973
|
27.526 ± 33.573
|
62.451 ± 89.896
|
0.2
|
0.5
|
0.5
|
- Expression of costimulatory molecules was quantified by calculating the ratio of target mRNA level to a background houskeeping β-actin mRNA and was defined as mean ± SD for three sample groups: cystic echinococcosis (CE), steatosis (SH) and chronic hepatitis (CH) (presented in bold)
